April Editorial
Which test to use to measure the anticoagulant effect of rivaroxaban: the prothrombin time test
Which test to use to measure the anticoagulant effect of rivaroxaban: the anti-factor Xa assay
Weibel–Palade bodies: a window to von Willebrand disease
Transcription factors in late megakaryopoiesis and related platelet disorders
The organizing principle of the platelet glycoprotein Ib–IX–V complex
Recommendations for thromboprophylaxis in the 2012 focused update of the ESC guidelines on atrial fibrillation: a commentary
Risk of venous thrombosis in patients with chronic kidney disease: identification of high-risk groups
Venous thrombosis risk assessment in medical inpatients: the medical inpatients and thrombosis (MITH) study
Prolonged outpatient vitamin K antagonist use and risk of venous thromboembolism in patients undergoing total hip or knee replacement
Hospitalization for vitamin-K-antagonist-related bleeding: treatment patterns and outcome
Systematic review on heparin-induced thrombocytopenia in children: a call to action
Enhancing the pharmacokinetic properties of recombinant factor VIII: first-in-human trial of glycoPEGylated recombinant factor VIII in patients with hemophilia A
Clot resolution after 3 weeks of anticoagulant treatment for pulmonary embolism: comparison of computed tomography and perfusion scintigraphy
Hestia criteria can safely select patients with pulmonary embolism for outpatient treatment irrespective of right ventricular function
Pre-analytical issues in the measurement of circulating microparticles: current recommendations and pending questions
Is a decrease of microparticles related to improvement of hemostasis after FVIII injection in hemophilia A patients treated on demand?
Direct inhibition of factor VIIa by TFPI and TFPI constructs
Genetic variants associated with protein C levels
Type I mutation in the F11 gene is a third ancestral mutation which causes factor XI deficiency in Ashkenazi Jews
Coagulation disorders and aortic stenosis: a chicken and egg question?
Impaired fibrinolysis is associated with the severity of aortic stenosis in humans
BMP receptor-integrin interaction mediates responses of vascular endothelial Smad1/5 and proliferation to disturbed flow
Measuring oral direct inhibitors of thrombin and factor Xa: a recommendation from the Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis
Guidance for diagnosis and treatment of disseminated intravascular coagulation from harmonization of the recommendations from three guidelines
Soluble endothelial protein C receptor and coagulation parameters as prognostic factors in non-small cell lung carcinoma
Munc13-4 is critical for thrombosis through regulating release of ADP from platelets
Distinct effects of Re- and S-forms of LPS on modulating platelet activation
Venous thromboembolism prophylaxis: do trial results enable clinicians and patients to evaluate whether the benefits justify the risk? Proceedings of an Ad Hoc Working Group Meeting
There's madness in their methods – a response to: Venous thromboembolism prophylaxis: do trial results enable clinicians and patients to evaluate whether the benefits justify the risk? Proceedings of an Ad Hoc Working Group Meeting
A response to – There's madness in their methods
Anticoagulant therapy for venous thromboembolism during pregnancy: a systematic review and a meta-analysis of the literature: a rebuttal
Anticoagulant therapy for venous thromboembolism during pregnancy: a systematic review and a meta-analysis of the literature: a reply to a rebuttal
Erratum
Join ISTH